« Biotech on a Shoestring? There's a Better Way | Main | UK to create £50 million cancer drugs fund »

07/27/2010

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a0120a77f675b970b013485bd0eb2970c

Listed below are links to weblogs that reference Biosimilars are Here to Stay - Deal with It!:

Comments

Feed You can follow this conversation by subscribing to the comment feed for this post.

bigredbruce

This item from Medical News Today (Aug 13th) lends further credence to the adoption of biosimilars -- as US physicians indicate that they will need less proof than their EU counterparts to prescribe these drugs
http://www.medicalnewstoday.com/articles/197640.php

bigredbruce

Further expansion on economic drivers that will support more use of generics (and ultimately biosimilars) from Pharmalot
http://www.pharmalot.com/2010/07/medicaid-wastes-millions-on-brand-name-meds-study/

The comments to this entry are closed.

My Photo
Blog powered by Typepad
Member since 12/2009
Bookmark and Share

April 2014

Sun Mon Tue Wed Thu Fri Sat
    1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30      

Innovate on Purpose

In the Pipeline

Life Sci VC


visited 6 states (46.1%)
Create your own visited map of Canada